Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 10;32(32):3600-6.
doi: 10.1200/JCO.2014.56.5838. Epub 2014 Aug 18.

Radiation field design in the ACOSOG Z0011 (Alliance) Trial

Reshma Jagsi  1 , Manjeet Chadha  2 , Janaki Moni  2 , Karla Ballman  2 , Fran Laurie  2 , Thomas A Buchholz  2 , Armando Giuliano  2 , Bruce G Haffty  2
Affiliations

Radiation field design in the ACOSOG Z0011 (Alliance) Trial

Reshma Jagsi et al. J Clin Oncol. .

Abstract

Purpose: ACOSOG Z0011 established that axillary lymph node dissection (ALND) is unnecessary in patients with breast cancer with one to two positive sentinel lymph nodes (SLNs) who undergo lumpectomy, radiotherapy (RT), and systemic therapy. We sought to ascertain RT coverage of the regional nodes in that trial.

Methods: We evaluated case report forms completed 18 months after enrollment. From 2012 to 2013, we collected all available detailed RT records for central review.

Results: Among 605 patients with completed case report forms, 89% received whole-breast RT. Of these, 89 (15%) were recorded as also receiving treatment to the supraclavicular region. Detailed RT records were obtained for 228 patients, of whom 185 (81.1%) received tangent-only treatment. Among 142 with sufficient records to evaluate tangent height, high tangents (cranial tangent border ≤ 2 cm from humeral head) were used in 50% of patients (33 of 66) randomly assigned to ALND and 52.6% (40 of 76) randomly assigned to SLND. Of the 228 patients with records reviewed, 43 (18.9%) received directed regional nodal RT using ≥ three fields: 22 in the ALND arm and 21 in the SLND arm. Those receiving directed nodal RT had greater nodal involvement (P < .001) than those who did not. Overall, there was no significant difference between treatment arms in the use of protocol-prohibited nodal fields.

Conclusion: Most patients treated in Z0011 received tangential RT alone, and some received no RT at all. Some patients received directed nodal irradiation via a third field. Further research is necessary to determine the optimal RT approach in patients with low-volume axillary disease treated with SLND alone.

PubMed Disclaimer

Conflict of interest statement

Authors' disclosures of potential conflicts of interest are found in the article online at www.jco.org. Author contributions are found at the end of this article.

Figures

Fig 1.
Fig 1.
CONSORT diagram. ALND, axillary lymph node dissection; SLND, sentinel lymph node dissection.
Fig 2.
Fig 2.
Representative examples of detailed radiation treatment records received and classified as receiving standard tangents, high tangents, or third-field treatment. (A) Standard tangents. (B) High tangents. (C and D) Third-field and matched tangents from a single patient.
Fig 3.
Fig 3.
Distribution of patients for whom detailed radiation treatment records were available. ALND, axillary lymph node dissection; PAB, posterior axillary boost; SC, supraclavicular; SLND, sentinel lymph node dissection.
See this image and copyright information in PMC

Comment in

References

    1. Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426–433. - PMC - PubMed
    1. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA. 2011;305:569–575. - PMC - PubMed
    1. Massimino KP, Hessman CJ, Ellis MC, et al. Impact of American College of Surgeons Oncology Group Z0011 and National Surgical Adjuvant Breast and Bowel Project B-32 trial results on surgeon practice in the Pacific Northwest. Am J Surg. 2012;203:618–622. - PubMed
    1. Gainer SM, Hunt KK, Beitsch P, et al. Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: A survey of the American Society of Breast Surgeons. Ann Surg Oncol. 2012;19:3152–3158. - PubMed
    1. Caudle AS, Hunt KK, Tucker SL, et al. American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on surgeon practice patterns. Ann Surg Oncol. 2012;19:3144–3151. - PMC - PubMed

Publication types

MeSH terms